154 related articles for article (PubMed ID: 19082483)
1. An integrative genomic and proteomic approach to chemosensitivity prediction.
Ma Y; Ding Z; Qian Y; Wan YW; Tosun K; Shi X; Castranova V; Harner EJ; Guo NL
Int J Oncol; 2009 Jan; 34(1):107-15. PubMed ID: 19082483
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity prediction by transcriptional profiling.
Staunton JE; Slonim DK; Coller HA; Tamayo P; Angelo MJ; Park J; Scherf U; Lee JK; Reinhold WO; Weinstein JN; Mesirov JP; Lander ES; Golub TR
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10787-92. PubMed ID: 11553813
[TBL] [Abstract][Full Text] [Related]
3. Predicting cancer drug response by proteomic profiling.
Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
5. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Nakatsu N; Yoshida Y; Yamazaki K; Nakamura T; Dan S; Fukui Y; Yamori T
Mol Cancer Ther; 2005 Mar; 4(3):399-412. PubMed ID: 15767549
[TBL] [Abstract][Full Text] [Related]
7. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.
Dan S; Tsunoda T; Kitahara O; Yanagawa R; Zembutsu H; Katagiri T; Yamazaki K; Nakamura Y; Yamori T
Cancer Res; 2002 Feb; 62(4):1139-47. PubMed ID: 11861395
[TBL] [Abstract][Full Text] [Related]
8. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
9. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity.
Hsu YC; Chen HY; Yuan S; Yu SL; Lin CH; Wu G; Yang PC; Li KC
BMC Med; 2013 Apr; 11():106. PubMed ID: 23590835
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action.
Covell DG
PLoS One; 2021; 16(4):e0243336. PubMed ID: 33909629
[TBL] [Abstract][Full Text] [Related]
12. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling.
Alaoui-Jamali MA; Dupré I; Qiang H
Drug Resist Updat; 2004; 7(4-5):245-55. PubMed ID: 15533762
[TBL] [Abstract][Full Text] [Related]
13. Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach.
Huang Y; Sadée W
Drug Discov Today; 2003 Apr; 8(8):356-63. PubMed ID: 12681939
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
Hsu DS; Balakumaran BS; Acharya CR; Vlahovic V; Walters KS; Garman K; Anders C; Riedel RF; Lancaster J; Harpole D; Dressman HK; Nevins JR; Febbo PG; Potti A
J Clin Oncol; 2007 Oct; 25(28):4350-7. PubMed ID: 17906199
[TBL] [Abstract][Full Text] [Related]
15. Relevance network between chemosensitivity and transcriptome in human hepatoma cells.
Moriyama M; Hoshida Y; Otsuka M; Nishimura S; Kato N; Goto T; Taniguchi H; Shiratori Y; Seki N; Omata M
Mol Cancer Ther; 2003 Feb; 2(2):199-205. PubMed ID: 12589037
[TBL] [Abstract][Full Text] [Related]
16. Current progress in the prediction of chemosensitivity for breast cancer.
Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Shimada H
Breast Cancer; 2004; 11(1):42-8. PubMed ID: 14718792
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.
Quintieri L; Fantin M; Vizler C
Adv Exp Med Biol; 2007; 593():95-104. PubMed ID: 17265720
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
[TBL] [Abstract][Full Text] [Related]
19. Methods and goals for the use of in vitro and in vivo chemosensitivity testing.
Blumenthal RD; Goldenberg DM
Mol Biotechnol; 2007 Feb; 35(2):185-97. PubMed ID: 17435285
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.
Györffy B; Surowiak P; Kiesslich O; Denkert C; Schäfer R; Dietel M; Lage H
Int J Cancer; 2006 Apr; 118(7):1699-712. PubMed ID: 16217747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
